circRNA Mining and mechanisms exploration in papillary thyroid carcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078812

Enrollment

Unknown

Registered

2023-12-19

Start date

2023-01-05

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Trail group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ?18-85 years old, regardless of gender; ? Papillary thyroid carcinoma confirmed by histopathological examination; ? Predicted survival time =12 weeks; ? no history of serious drug allergy; ? Patients voluntarily participated in the study and signed the corresponding written informed consent

Exclusion criteria

Exclusion criteria: ? History of acute injury, infection and surgery in the past 3 months; ? Severe abnormal liver and kidney function; ? current use of anti-inflammatory drugs; ? blood system diseases before treatment; ? patients with other malignant tumors; ? autoimmune disease diagnosed before treatment or use of steroid drugs for more than 1 month; ? Mental illness or cognitive impairment.

Design outcomes

Primary

Measure	Time frame
total RNA;	—

Secondary

Measure	Time frame
Thyroid stimulating hormone;	—

Countries

China

Contacts

Public ContactTinajiao Zhou

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

g063048@sjtu.edu.cn+86 139 1632 7993

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026